4.5 Article

MRSA nasal colonization burden and risk of MRSA infection

期刊

AMERICAN JOURNAL OF INFECTION CONTROL
卷 41, 期 5, 页码 405-410

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.ajic.2012.07.017

关键词

Staphylococcus aureus; Carriage quantification; Cycle threshold

资金

  1. PHS Grant from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources [UL RR025008]

向作者/读者索取更多资源

Background: Staphylococcus aureus nasal colonization burden has been identified as a risk factor for infection. This study evaluates methicillin-resistant S aureus (MRSA) nasal burden, as defined by the cycle threshold (C-t) and risk of subsequent infection. Methods: In a retrospective cohort study, United States veterans were classified into 3 MRSA nasal colonization groups: noncarriers, low burden (C-t > 24 cycles), and high burden (C-t <= 24 cycles). MRSA infections were identified prospectively, and clinical information was obtained by chart review. Multivariate logistic regression assessed the association of MRSA nasal burden and risk of MRSA infection. Results: During 4-years of follow-up, 4.3% of noncarriers, 18.5% of low burden, and 17.2% of high burden developed a MRSA infection. In multivariate analysis, MRSA nasal colonization was a risk factor for MRSA infection (P = .008) with low burden (risk ratio [RR], 3.62; 95% confidence interval [CI]: 1.47-8.93) and high burden (RR, 2.71; 95% CI: 0.95-7.72) associated with subsequent MRSA infection when compared with noncarriers. When compared with low burden, high burden nasal carriers were not at increased risk of infection (RR, 0.75; 95% CI 0.36-1.55). Conclusion: MRSA nasal colonization was a risk factor for MRSA infection. High nasal burden of MRSA did not increase the risk of infection. Copyright (c) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据